Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations.

Calderwood SK, Gong J, Stevenson MA, Murshid A.

Int J Hyperthermia. 2013 Aug;29(5):376-9. doi: 10.3109/02656736.2013.792126. Review.

2.

The 'peptidome' of tumour-derived chaperone-rich cell lysate anti-cancer vaccines reveals potential tumour antigens that stimulate tumour immunity.

Graner MW, Romanoski A, Katsanis E.

Int J Hyperthermia. 2013 Aug;29(5):380-9. doi: 10.3109/02656736.2013.793406.

PMID:
23725202
3.

Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation.

Weng D, Song B, Koido S, Calderwood SK, Gong J.

J Immunol. 2013 Jul 15;191(2):755-63. doi: 10.4049/jimmunol.1203286.

4.

Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells.

Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, Xing PX, Calderwood SK, Gong J.

J Immunol. 2006 Nov 1;177(9):5946-55.

5.

Intracellular and extracellular Hsp70 chaperone as a target for cancer therapy.

Guzhova IV, Shevtsov MA, Abkin SV, Pankratova KM, Margulis BA.

Int J Hyperthermia. 2013 Aug;29(5):399-408. doi: 10.3109/02656736.2013.807439. Review.

PMID:
23845032
6.

Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells.

Weng D, Calderwood SK, Gong J.

Methods Mol Biol. 2011;787:255-65. doi: 10.1007/978-1-61779-295-3_19.

7.

A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.

Qu P, Ma JH, Zhang XM, Huang XJ, Yang XW, Yan-Fang S.

Indian J Exp Biol. 2010 May;48(5):436-43.

PMID:
20795360
8.

Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.

Ye J, Chen GS, Song HP, Li ZS, Huang YY, Qu P, Sun YJ, Zhang XM, Sui YF.

Cancer Immunol Immunother. 2004 Sep;53(9):825-34.

PMID:
15127237
9.

Efficient induction of a Her2-specific anti-tumor response by dendritic cells pulsed with a Hsp70L1-Her2(341-456) fusion protein.

Fu Q, Wu Y, Yan F, Wang N, Wang W, Cao X, Wang Y, Wan T.

Cell Mol Immunol. 2011 Sep;8(5):424-32. doi: 10.1038/cmi.2011.21.

10.

Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy.

Li Y, Subjeck J, Yang G, Repasky E, Wang XY.

Vaccine. 2006 Jun 19;24(25):5360-70.

PMID:
16714072
11.

Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.

Ma JH, Sui YF, Ye J, Huang YY, Li ZS, Chen GS, Qu P, Song HP, Zhang XM.

Cancer Immunol Immunother. 2005 Sep;54(9):907-14.

PMID:
15756604
12.
13.

Human prostate stem cell antigen and HSP70 fusion protein vaccine inhibits prostate stem cell antigen-expressing tumor growth in mice.

Dong L, Zhang X, Ren J, Wu S, Yu T, Hou L, Fu L, Yi S, Yu C.

Cancer Biother Radiopharm. 2013 Jun;28(5):391-7. doi: 10.1089/cbr.2012.1357.

PMID:
23701419
14.

Could mycobacterial Hsp70-containing fusion protein lead the way to an affordable therapeutic cancer vaccine?

Brauns T, Leblanc P, Gelfand JA, Poznanski M.

Expert Rev Vaccines. 2015 Mar;14(3):435-46. doi: 10.1586/14760584.2015.979797. Review.

PMID:
25496347
15.

Hsp70-like protein 1 fusion protein enhances induction of carcinoembryonic antigen-specific CD8+ CTL response by dendritic cell vaccine.

Wu Y, Wan T, Zhou X, Wang B, Yang F, Li N, Chen G, Dai S, Liu S, Zhang M, Cao X.

Cancer Res. 2005 Jun 1;65(11):4947-54.

16.

Enhanced immunity against hepatoma induced by dendritic cells pulsed with Hsp70-H22 peptide complexes and CD40L.

Gao J, Luo SM, Peng ML, Deng T.

J Cancer Res Clin Oncol. 2012 Jun;138(6):917-26. doi: 10.1007/s00432-012-1166-6.

PMID:
22327301
17.

Heat shock protein derived from a non-autologous tumour can be used as an anti-tumour vaccine.

Casey DG, Lysaght J, James T, Bateman A, Melcher AA, Todryk SM.

Immunology. 2003 Sep;110(1):105-11.

18.
19.

Cancer immunotherapy using irradiated tumor cells secreting heat shock protein 70.

Chang CL, Tsai YC, He L, Wu TC, Hung CF.

Cancer Res. 2007 Oct 15;67(20):10047-57.

Supplemental Content

Support Center